Evidence map›Paper›PMID 24618463›Full record

ArticleBioinformatics (Oxford, England)2014

A gradient-boosting approach for filtering de novo mutations in parent-offspring trios.

Yongzhuang Liu, Bingshan Li, Renjie Tan, Xiaolin Zhu, Yadong Wang

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Automated Identification of GermlinebioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Where Do We Stand in Regularization for Life Science Studies?Journal of computational biology : a journal of computational molecular cell biology · 2022
    Article
  9. Article
  10. Contributions of de novo variants to systemic lupus erythematosus.European journal of human genetics : EJHG · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yongzhuang LiuSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USASchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Bingshan LiSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Renjie TanSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USASchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Xiaolin ZhuSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Yadong WangSchool of Computer Science and Technology, Harbin Institute of Technology, Harbin 150001, China, Center for Human Genome Variation, Duke University, Durham, NC 27708 and Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37235, USA.
Duke University · USHarbin Institute of Technology · CN

Funding

The Epilepsy Phenome/ Genome Project (EPGP)U01NS053998 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOWENSTEIN, DANIEL H · 2007 to 2013
$26.4M
3 of 7 Epi4K: Sequencing, Biostatistics & Bioinformatics CoreU01NS077303 · NINDS · DUKE UNIVERSITY · PI EICHLER, EVAN, GOLDSTEIN, DAVID B. · 2011 to 2018
$13.3M
2 of 7 EPI4K - Phenotyping Clinical Informatics Core U01NS077276 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LOWENSTEIN, DANIEL H · 2011 to 2015
$3.1M
Design and analysis of sequencing studies for gene mapping in familiesR01HG006857 · NHGRI · VANDERBILT UNIVERSITY · PI LI, BINGSHAN · 2013 to 2016
$1.5M
4 of 7: Epi4K: Epileptic Encephalopathies ProjectU01NS077364 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHERR, ELLIOTT · 2011 to 2013
$827k
NINDS NIH HHS U01 NS053998NINDS NIH HHS U01-NS053998NINDS NIH HHS U01 NS077276NINDS NIH HHS U01-NS077276NINDS NIH HHS U01 NS077303NINDS NIH HHS U01-NS077303NINDS NIH HHS U01 NS077364NINDS NIH HHS U01-NS077364
6 · The paper itself

Abstract

motivationWhole-genome and -exome sequencing on parent-offspring trios is a powerful approach to identifying disease-associated genes by detecting de novo mutations in patients. Accurate detection of de novo mutations from sequencing data is a critical step in trio-based genetic studies. Existing bioinformatic approaches usually yield high error rates due to sequencing artifacts and alignment issues, which may either miss true de novo mutations or call too many false ones, making downstream validation and analysis difficult. In particular, current approaches have much worse specificity than sensitivity, and developing effective filters to discriminate genuine from spurious de novo mutations remains an unsolved challenge.

resultsIn this article, we curated 59 sequence features in whole genome and exome alignment context which are considered to be relevant to discriminating true de novo mutations from artifacts, and then employed a machine-learning approach to classify candidates as true or false de novo mutations. Specifically, we built a classifier, named De Novo Mutation Filter (DNMFilter), using gradient boosting as the classification algorithm. We built the training set using experimentally validated true and false de novo mutations as well as collected false de novo mutations from an in-house large-scale exome-sequencing project. We evaluated DNMFilter's theoretical performance and investigated relative importance of different sequence features on the classification accuracy. Finally, we applied DNMFilter on our in-house whole exome trios and one CEU trio from the 1000 Genomes Project and found that DNMFilter could be coupled with commonly used de novo mutation detection approaches as an effective filtering approach to significantly reduce false discovery rate without sacrificing sensitivity. AVAILABILITY: The software DNMFilter implemented using a combination of Java and R is freely available from the website at http://humangenome.duke.edu/software.

Indexed as

MutationAlgorithmsArtificial IntelligenceExomeFemaleGenomeHumansSoftware

Identifiers

PMID24618463
PMCPMC4071207
OpenAlexW2139327842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.